EGFR and colorectal carcinoma: Here we have demonstrated that proliferation of CRC cell lines was highly inhibited in cells that expressed EGFR at high levels, which suggests that EGFR expression levels detected by cetuximab correlate with the sensitivity of cells to cetuximab treatment.